Want to join the conversation?
Global drugmaker $AGN today received an US FDA approval to promote JUVEDERM ULTRA XC injectable gel. This injectable gel is used for lip augmentation in adults over the age of 21 that lasts up to one year. JUVEDERM ULTRA XC is created from hyaluronic acid and it also contains a small amount of lidocaine, a local anesthetic drug.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.